{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:11:29Z","timestamp":1782537089945,"version":"3.54.5"},"reference-count":79,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.amjms.2025.08.004","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:31:17Z","timestamp":1754429477000},"page":"409-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of testosterone deficiency and therapy on the cardiometabolic syndrome in men"],"prefix":"10.1016","volume":"370","author":[{"given":"Farid","family":"Saad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmaged M","family":"Traish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.amjms.2025.08.004_bib0001","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1161\/ATVBAHA.107.154195","article-title":"Is metabolic syndrome the main threat to human health in the twenty-first century?","volume":"27","author":"Taskinen","year":"2007","journal-title":"Arter Thromb Vasc Biol"},{"key":"10.1016\/j.amjms.2025.08.004_bib0002","first-page":"545","article-title":"Das metabolische Syndrom","volume":"36","author":"Hanefeld","year":"1981","journal-title":"Dtsch Gesundheitwes"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.004_bib0003","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2164\/jandrol.108.005215","article-title":"The dark side of testosterone deficiency: I. metabolic syndrome and erectile dysfunction","volume":"30","author":"Traish","year":"2009","journal-title":"J Androl"},{"issue":"5\u20136","key":"10.1016\/j.amjms.2025.08.004_bib0004","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech"},{"issue":"9468","key":"10.1016\/j.amjms.2025.08.004_bib0005","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.amjms.2025.08.004_bib0006","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.amjms.2025.08.004_bib0007","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5551\/jat.12.295","article-title":"The metabolic syndrome: a global public health problem and a new definition","volume":"12","author":"Zimmet","year":"2005","journal-title":"J Atheroscler Thromb"},{"issue":"16","key":"10.1016\/j.amjms.2025.08.004_bib0008","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.amjms.2025.08.004_bib0009","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"American Heart Association, National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.amjms.2025.08.004_bib0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"Comment on the provisional report from the WHO consultation: european Group for the Study of Insulin Resistance (EGIR)","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.004_bib0011","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5551\/jat.12.295","article-title":"The metabolic syndrome: a global public health problem and a new definition","volume":"12","author":"Zimmet","year":"2005","journal-title":"J Atheroscler Thromb"},{"issue":"12","key":"10.1016\/j.amjms.2025.08.004_bib0012","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0300-8932(05)74065-3","article-title":"A new International Diabetes Federation (IDF) worldwide definition of the metabolic syndrome: the rationale and the results","volume":"58","author":"Zimmet","year":"2005","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"7","key":"10.1016\/j.amjms.2025.08.004_bib0013","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.amjmed.2010.12.027","article-title":"Testosterone deficiency","volume":"124","author":"Traish","year":"2011","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.amjms.2025.08.004_bib0014","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.mayocp.2016.04.007","article-title":"Fundamental concepts regarding testosterone deficiency and treatment: international expert consensus resolutions","volume":"91","author":"Morgentaler","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.amjms.2025.08.004_bib0015","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2004-1158","article-title":"Endogenous sex hormones and metabolic syndrome in aging men","volume":"90","author":"Muller","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.004_bib0016","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1210\/jc.2005-1326","article-title":"Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men","volume":"91","author":"Kupelian","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.amjms.2025.08.004_bib0017","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1210\/jc.2008-0054","article-title":"Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups","volume":"93","author":"Kupelian","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.004_bib0018","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.ijir.3901499","article-title":"Epidemiology: testosterone and the metabolic syndrome","volume":"19","author":"Svartberg","year":"2007","journal-title":"Int J Impot Res"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.004_bib0019","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/eje.0.1490601","article-title":"Sex hormones, inflammation and the metabolic syndrome: a population-based study","volume":"149","author":"Laaksonen","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.amjms.2025.08.004_bib0020","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diacare.27.5.1036","article-title":"Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men","volume":"27","author":"Laaksonen","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.004_bib0021","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1210\/jc.2004-0970","article-title":"The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study","volume":"90","author":"Laaksonen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.amjms.2025.08.004_bib0022","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1210\/jc.2014-4184","article-title":"Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European men","volume":"100","author":"Antonio","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.004_bib0023","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/ije\/dyq158","article-title":"Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"40","author":"Brand","year":"2011","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.amjms.2025.08.004_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100409","article-title":"Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies","volume":"9","author":"Brand","year":"2014","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.amjms.2025.08.004_bib0025","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0026-0495(90)90297-P","article-title":"Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels","volume":"39","author":"Seidell","year":"1990","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.004_bib0026","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.sxmr.2017.01.003","article-title":"Testosterone replacement therapy and components of the metabolic syndrome","volume":"5","author":"Anaissie","year":"2017","journal-title":"Sex Med Rev"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.004_bib0027","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1743-6109.2010.01991.x","article-title":"Testosterone and metabolic syndrome: a meta-analysis study","volume":"8","author":"Corona","year":"2011","journal-title":"J Sex Med"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.004_bib0028","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.beem.2010.07.002","article-title":"Testosterone, cardiovascular disease and the metabolic syndrome","volume":"25","author":"Corona","year":"2011","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.amjms.2025.08.004_bib0029","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/and.12305","article-title":"Male hypogonadism and metabolic syndrome","volume":"47","author":"Naifar","year":"2015","journal-title":"Andrologia"},{"issue":"9","key":"10.1016\/j.amjms.2025.08.004_bib0030","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1210\/jc.2006-2764","article-title":"Aging, androgens, and the metabolic syndrome in a longitudinal study of aging","volume":"92","author":"Rodriguez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.amjms.2025.08.004_bib0031","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1210\/jc.2008-2416","article-title":"Lower testosterone levels predict incident stroke and transient ischemic attack in older men","volume":"94","author":"Yeap","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.amjms.2025.08.004_bib0032","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1530\/EJE-09-0348","article-title":"Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study","volume":"161","author":"Yeap","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.004_bib0033","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11154-015-9323-2","article-title":"The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease","volume":"16","author":"Traish","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"10.1016\/j.amjms.2025.08.004_bib0034","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1080\/13685538.2020.1764927","article-title":"Association between metabolic syndrome, hepatic steatosis, and testosterone deficiency: evidences from studies with men and rodents","volume":"23","author":"Hermoso","year":"2020","journal-title":"Aging Male"},{"issue":"7","key":"10.1016\/j.amjms.2025.08.004_bib0035","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1742-1241.2006.00992.x","article-title":"Prevalence of hypogonadism in males aged at least 45 years: the HIM study","volume":"60","author":"Mulligan","year":"2006","journal-title":"Int J Clin Pr"},{"issue":"Suppl. 3","key":"10.1016\/j.amjms.2025.08.004_bib0036","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.3949\/ccjm.74.Suppl_3.S38","article-title":"Evolving issues in male hypogonadism: evaluation, management, and related comorbidities","volume":"74","author":"Miner","year":"2007","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"10.1016\/j.amjms.2025.08.004_bib0037","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1742-1241.2007.01317.x","article-title":"Testosterone and aging: what we have learned since the Institute of Medicine and what lies ahead","volume":"61","author":"Miner","year":"2007","journal-title":"Int J Clin Pr"},{"issue":"8","key":"10.1016\/j.amjms.2025.08.004_bib0038","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.metabol.2005.03.006","article-title":"Contribution of age and declining androgen levels to features of the metabolic syndrome in men","volume":"54","author":"Blouin","year":"2005","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.004_bib0039","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1677\/joe.1.06365","article-title":"Androgen inactivation and steroid converting enzyme expression in abdominal adipose tissue in men","volume":"191","author":"Blouin","year":"2006","journal-title":"J Endocrinol"},{"issue":"8","key":"10.1016\/j.amjms.2025.08.004_bib0040","first-page":"2839","article-title":"Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men","volume":"85","author":"Wang","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.amjms.2025.08.004_bib0041","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2003-032006","article-title":"Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.amjms.2025.08.004_bib0042","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2337\/dc10-2339","article-title":"Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes","volume":"34","author":"Wang","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.004_bib0043","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/eje.1.02166","article-title":"Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes","volume":"154","author":"Kapoor","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.004_bib0044","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2164\/jandrol.108.007005","article-title":"Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone","volume":"30","author":"Heufelder","year":"2009","journal-title":"J Androl"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.004_bib0045","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1532-5415.2010.02865.x","article-title":"Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty","volume":"58","author":"Kenny","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"10.1016\/j.amjms.2025.08.004_bib0046","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/BF03350341","article-title":"Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome","volume":"33","author":"Aversa","year":"2010","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"10.1016\/j.amjms.2025.08.004_bib0047","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1111\/j.1743-6109.2010.01931.x","article-title":"Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study","volume":"7","author":"Aversa","year":"2010","journal-title":"J Sex Med"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.004_bib0048","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1210\/jc.2009-1251","article-title":"Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study","volume":"95","author":"Srinivas-Shankar","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.amjms.2025.08.004_bib0049","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc10-1233","article-title":"TIMES2 Investigators. Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study)","volume":"34","author":"Jones","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.004_bib0050","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/jsm.12146","article-title":"Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes","volume":"10","author":"Hackett","year":"2013","journal-title":"J Sex Med"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.004_bib0051","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/ijcp.12319","article-title":"Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study","volume":"68","author":"Traish","year":"2014","journal-title":"Int J Clin Pr"},{"issue":"10","key":"10.1016\/j.amjms.2025.08.004_bib0052","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/oby.20407","article-title":"Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss","volume":"21","author":"Saad","year":"2013","journal-title":"Obes (Silver Spring)"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.004_bib0053","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ijo.2015.139","article-title":"Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies","volume":"40","author":"Saad","year":"2016","journal-title":"Int J Obes (L)"},{"issue":"5","key":"10.1016\/j.amjms.2025.08.004_bib0054","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2265.2010.03845.x","article-title":"Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study","volume":"73","author":"Kalinchenko","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.004_bib0055","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1111\/dom.15520","article-title":"Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase","volume":"26","author":"Tishova","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.004_bib0056","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.urology.2013.08.019","article-title":"Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome","volume":"83","author":"Francomano","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.amjms.2025.08.004_bib0057","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/527470","article-title":"Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome","volume":"2014","author":"Francomano","year":"2014","journal-title":"Int J Endocrinol"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.004_bib0058","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2337\/dc18-2388","article-title":"Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a registry study","volume":"42","author":"Yassin","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.004_bib0059","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41366-019-0517-7","volume":"44","author":"Saad","year":"2020","journal-title":"Int J Obes (L)"},{"issue":"11","key":"10.1016\/j.amjms.2025.08.004_bib0060","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/dom.14122","article-title":"Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study","volume":"22","author":"Haider","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.amjms.2025.08.004_bib0061","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/andr.13626","article-title":"TRACK_9: testosterone replacement assessment: classical vs. functional hypogonadism - knowledge from a 9-year study","volume":"12","author":"Zitzmann","year":"2024","journal-title":"Andrology"},{"issue":"1\u20132","key":"10.1016\/j.amjms.2025.08.004_bib0062","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jsbmb.2008.12.022","article-title":"The role of testosterone in the metabolic syndrome: a review","volume":"114","author":"Saad","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"12","key":"10.1016\/j.amjms.2025.08.004_bib0063","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrendo.2009.212","article-title":"Testosterone deficiency, insulin resistance and the metabolic syndrome","volume":"5","author":"Zitzmann","year":"2009","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.004_bib0064","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/1008-682X.148068","article-title":"Testosterone and metabolic syndrome","volume":"17","author":"Cunningham","year":"2015","journal-title":"Asian J Androl"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.004_bib0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/01.ju.0000169490.78443.59","article-title":"Hypogonadism and metabolic syndrome: implications for testosterone therapy","volume":"174","author":"Makhsida","year":"2005","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.004_bib0066","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.sxmr.2018.12.004","article-title":"Metabolic effects of testosterone therapy in men with type 2 diabetes and metabolic syndrome","volume":"7","author":"Hackett","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.amjms.2025.08.004_bib0067","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4732021","article-title":"Metabolic Effects of Testosterone replacement therapy in patients with type 2 diabetes mellitus or metabolic syndrome: a meta-analysis","volume":"2020","author":"Li","year":"2020","journal-title":"Int J Endocrinol"},{"issue":"7","key":"10.1016\/j.amjms.2025.08.004_bib0068","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3810\/pgm.2014.11.2843","article-title":"Testosterone supplementation therapy in the treatment of patients with metabolic syndrome","volume":"126","author":"Kovac","year":"2014","journal-title":"Postgr Med"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.004_bib0069","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cen.12664","article-title":"Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"83","author":"Grossmann","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.amjms.2025.08.004_bib0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrendo.2013.122","article-title":"Testosterone and insulin resistance in the metabolic syndrome and T2DM in men","volume":"9","author":"Rao","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.004_bib0071","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2017-00234","article-title":"Lessons from the testosterone trials","volume":"39","author":"Snyder","year":"2018","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.004_bib0072","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","article-title":"Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial","volume":"9","author":"Wittert","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.amjms.2025.08.004_bib0073","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.48692","article-title":"Prostate safety events during testosterone replacement therapy in men with hypogonadism: a randomized clinical trial","volume":"6","author":"Bhasin","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.004_bib0074","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/bju.14536","article-title":"Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors","volume":"123","author":"Hackett","year":"2019","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.004_bib0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/cen.12936","article-title":"Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men","volume":"84","author":"Yassin","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"22","key":"10.1016\/j.amjms.2025.08.004_bib0076","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212221","article-title":"Effects of testosterone replacement therapy on metabolic syndrome in male patients - systematic review","volume":"25","author":"Mlynarz","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.amjms.2025.08.004_bib0077","article-title":"The inverse association between testosterone replacement therapy and cardiovascular disease risk: a systematic 25-year review and meta-analysis analysis of prospective cohort studies from 1999 to 2024","volume":"3","author":"Borges","year":"2024","journal-title":"Int J Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.004_bib0078","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Nissen SE; TRAVERSE Study Investigators. Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.08.004_bib0079","unstructured":"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-issues-class-wide-labeling-changes-testosterone-products accessed 2025-04-15."}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925011383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925011383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T18:49:38Z","timestamp":1760467778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925011383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0002962925011383"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.08.004","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of testosterone deficiency and therapy on the cardiometabolic syndrome in men","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}